Pantera

Pantera was jointly established as a joint venture in September 2022 by IBA, a Belgian particle accelerator developer, and SCK CEN, the Belgian Nuclear Research Centre. Pantera's goal is to ensure the large-scale production of Ac-225, one of the most promising α-radioisotopes for use in cancer treatment. By achieving mass production of this isotope, Pantera’s ultimate objective is to improve the accessibility of future innovative Ac-225-based cancer therapies.